Relationship between left atrial/left ventricular diameter ratio and outcomes in patients with hypertrophic cardiomyopathy

IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of cardiology Pub Date : 2024-09-10 DOI:10.1016/j.jjcc.2024.09.003
Keigo Kanbayashi MD, Yuichiro Minami MD PhD FJCC, Shintaro Haruki MD PhD, Chihiro Saito MD PhD, Junichi Yamaguchi MD PhD FJCC
{"title":"Relationship between left atrial/left ventricular diameter ratio and outcomes in patients with hypertrophic cardiomyopathy","authors":"Keigo Kanbayashi MD, Yuichiro Minami MD PhD FJCC, Shintaro Haruki MD PhD, Chihiro Saito MD PhD, Junichi Yamaguchi MD PhD FJCC","doi":"10.1016/j.jjcc.2024.09.003","DOIUrl":null,"url":null,"abstract":"Although diastolic dysfunction is the main pathophysiological feature of hypertrophic cardiomyopathy (HCM), it remains to be clarified whether parameters of diastolic function can reliably determine HCM prognosis. In patients with reduced left ventricular (LV) distensibility, chronic elevation of LV diastolic pressure is seen with a smaller than expected LV size. Accordingly, patients with HCM with severe LV diastolic dysfunction typically demonstrate left atrial (LA) dilation and a disproportionately smaller left ventricle. Therefore, we investigated the relationship between LA/LV diameter ratio, as a potential indicator of disease progression, and outcomes in patients with HCM. We included 468 patients in whom LA and LV end-diastolic diameter were successfully evaluated by echocardiography at the initial assessment. We divided the patients into two groups: those with an LA/LV diameter ratio > 1 and those with an LA/LV diameter ratio ≤ 1. We compared the HCM-related death rates between the two groups. Of the 468 patients, 96 patients (20.5 %) with HCM showed an LA/LV diameter ratio > 1. In the univariate analysis, patients with an LA/LV diameter ratio > 1 had a significantly greater likelihood of HCM-related death than patients with an LA/LV diameter ratio ≤ 1 (log-rank = 0.002). In the multivariate Cox proportional hazards analysis, when including LA/LV diameter ratio > 1 and imbalanced baseline variables, an LA/LV diameter ratio > 1 was an independent determinant of HCM-related death (adjusted hazard ratio: 1.87, 95 % confidence interval: 1.08–3.24; = 0.024). LA/LV diameter ratio can be easily evaluated and may be useful for risk stratification of HCM-related death in patients with HCM.","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jjcc.2024.09.003","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Although diastolic dysfunction is the main pathophysiological feature of hypertrophic cardiomyopathy (HCM), it remains to be clarified whether parameters of diastolic function can reliably determine HCM prognosis. In patients with reduced left ventricular (LV) distensibility, chronic elevation of LV diastolic pressure is seen with a smaller than expected LV size. Accordingly, patients with HCM with severe LV diastolic dysfunction typically demonstrate left atrial (LA) dilation and a disproportionately smaller left ventricle. Therefore, we investigated the relationship between LA/LV diameter ratio, as a potential indicator of disease progression, and outcomes in patients with HCM. We included 468 patients in whom LA and LV end-diastolic diameter were successfully evaluated by echocardiography at the initial assessment. We divided the patients into two groups: those with an LA/LV diameter ratio > 1 and those with an LA/LV diameter ratio ≤ 1. We compared the HCM-related death rates between the two groups. Of the 468 patients, 96 patients (20.5 %) with HCM showed an LA/LV diameter ratio > 1. In the univariate analysis, patients with an LA/LV diameter ratio > 1 had a significantly greater likelihood of HCM-related death than patients with an LA/LV diameter ratio ≤ 1 (log-rank = 0.002). In the multivariate Cox proportional hazards analysis, when including LA/LV diameter ratio > 1 and imbalanced baseline variables, an LA/LV diameter ratio > 1 was an independent determinant of HCM-related death (adjusted hazard ratio: 1.87, 95 % confidence interval: 1.08–3.24; = 0.024). LA/LV diameter ratio can be easily evaluated and may be useful for risk stratification of HCM-related death in patients with HCM.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肥厚型心肌病患者左心房/左心室直径比与预后之间的关系
尽管舒张功能障碍是肥厚型心肌病(HCM)的主要病理生理特征,但舒张功能参数是否能可靠地判断 HCM 的预后仍有待明确。在左心室(LV)扩张性降低的患者中,左心室舒张压长期升高,左心室尺寸小于预期。因此,左心室舒张功能严重障碍的 HCM 患者通常表现为左心房(LA)扩张和左心室不成比例地变小。因此,我们研究了作为疾病进展潜在指标的 LA/LV 直径比与 HCM 患者预后之间的关系。我们纳入了 468 例在初次评估时通过超声心动图成功评估了 LA 和左心室舒张末期直径的患者。我们将患者分为两组:LA/LV 直径比大于 1 的患者和 LA/LV 直径比小于 1 的患者。我们比较了两组患者与 HCM 相关的死亡率。在 468 例患者中,96 例(20.5%)HCM 患者的 LA/LV 直径比大于 1。在单变量分析中,LA/LV 直径比 > 1 的患者发生 HCM 相关死亡的可能性明显高于 LA/LV 直径比 ≤ 1 的患者(log-rank = 0.002)。在多变量 Cox 比例危险分析中,当包括 LA/LV 直径比 > 1 和不平衡基线变量时,LA/LV 直径比 > 1 是 HCM 相关死亡的独立决定因素(调整后危险比:1.87,95 % 置信区间:1.08-3.24;= 0.024)。LA/LV 直径比易于评估,可能有助于对 HCM 患者与 HCM 相关的死亡进行风险分层。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of cardiology
Journal of cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
4.90
自引率
8.00%
发文量
202
审稿时长
29 days
期刊介绍: The official journal of the Japanese College of Cardiology is an international, English language, peer-reviewed journal publishing the latest findings in cardiovascular medicine. Journal of Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a selection of review articles, clinical trials, short communications, and important messages and letters to the editor.
期刊最新文献
Associations of adipose tissue depots with cardiac resynchronization therapy response and clinical outcomes: A CRT-HF Clinic substudy. Association between complementary use of Goreisan (a Japanese herbal Kampo medicine) and heart failure readmission: A Nationwide propensity score-matched study. Clinical Characteristics and Short-Term Outcomes in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support Escalation From Intra-Aortic Balloon Pump to Impella: From the J-PVAD Registry. The role of left atrium posterior wall isolation in patients undergoing catheter ablation for atrial fibrillation. Impact of Diabetes Mellitus on Post-CABG Outcomes in Veterans: Insights from the REGROUP Trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1